Related Experiment Video
Updated: May 12, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Human papillomavirus E1 proteins inhibit RIG-I/MDA5-MAVS, TLR3-TRIF, cGAS-STING, and JAK-STAT signaling pathways to
Jin-Xin Li1, Jing Zhang1, Cheng-Hao Li2
1Department of Infectious Disease and Hepatology, The Second Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Abstract:
Human papillomavirus (HPV) is a major etiological agent of both malignant and benign lesions, with high-risk types, such as HPV16 and HPV18, being strongly linked to cervical cancer, while low-risk types like HPV11 are associated with benign conditions. While viral proteins such as E6 and E7 are well-established regulators of immune evasion, the role of E1 in modulating the host antiviral responses remains insufficiently characterized. This study investigates the immunomodulatory functions of HPV16 and HPV11 E1 in suppressing innate antiviral immune signaling pathways. Through a combination of RT-qPCR and luciferase reporter assays, we demonstrate that E1 suppresses the production of interferons and interferon-stimulated genes triggered by viral infections and the activation of RIG-I/MDA5-MAVS, TLR3-TRIF, cGAS-STING, and JAK-STAT pathways. Co-immunoprecipitation assays reveal that E1 interacts directly with key signaling molecules within these pathways. E1 also impairs TBK1 and IRF3 phosphorylation and obstructs the nuclear translocation of IRF3, thereby broadly suppressing IFN responses. Additionally, E1 disrupts the JAK-STAT pathway by binding STAT1, which prevents the assembly and nuclear localization of the ISGF3 complex containing STAT1, STAT2, and IRF9, thereby further diminishing antiviral response. These findings establish E1 as a pivotal regulator of immune evasion and suggest its potential as a novel therapeutic target to enhance antiviral immunity in HPV-associated diseases.
Insights
Human papillomavirus E1 protein suppresses key antiviral signaling pathways, including interferon production. This immune evasion mechanism highlights E1 as a potential therapeutic target for HPV-associated diseases.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Human papillomavirus (HPV) causes benign and malignant lesions.
- High-risk HPV types (e.g., HPV16, HPV18) are linked to cervical cancer.
- HPV E6 and E7 proteins are known for immune evasion, but E1's role is unclear.
Purpose of the Study:
- Investigate the immunomodulatory functions of HPV16 and HPV11 E1 proteins.
- Determine how E1 affects host innate antiviral immune signaling pathways.
- Characterize E1's role in viral immune evasion.
Main Methods:
- RT-qPCR to measure gene expression.
- Luciferase reporter assays to assess pathway activation.
- Co-immunoprecipitation to identify protein interactions.
Main Results:
- HPV E1 suppresses interferon and interferon-stimulated gene production.
- E1 inhibits RIG-I/MDA5-MAVS, TLR3-TRIF, cGAS-STING, and JAK-STAT pathways.
- E1 interacts with signaling molecules, impairs IRF3 phosphorylation, and blocks its nuclear translocation.
- E1 disrupts the JAK-STAT pathway by binding STAT1, preventing ISGF3 complex formation.
Conclusions:
- HPV E1 is a significant regulator of immune evasion by suppressing innate antiviral responses.
- E1 targets multiple key signaling pathways, including interferon and JAK-STAT.
- E1 represents a potential therapeutic target for enhancing antiviral immunity in HPV infections.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Leaky Scanning
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
The JAK-STAT Signaling Pathway

